Hicksville, NY -- February 20, 2018 -- InvestorsHub
NewsWire -- Canbiola, Inc. (OTC PINK: CANB) is
pleased to announce the hire of Mr. David Posel as the Chief
Operations Officer.
“We are excited that Mr. Posel is joining the Canbiola
team. Mr. Posel is a pioneer in the CBD industry and his many years
of experience in Operations and Manufacturing will allow our
company to better manage our growth,” said Marco Alfonsi, Canbiola
CEO. “David has the perfect background, having participated in the
industry since its early stages.”
“I am really excited to come aboard and work with Canbiola,
a fantastic and robust company. Our goal at Canbiola will be to
formulate new products and to continuously improve our product
quality. We will be focusing on natural products that symbiotically
work with the bio-absorption and bio-delivery systems within the
human body and we are poised to deliver the most advanced CBD
products across the board,” said Mr. Posel.
As the Chief Operations Officer of Canbiola, David will
expand the company’s product lines across the board, engage market
leaders and produce first-to-market products for CBD industry
worldwide.
David Posel started his earliest years as a metallurgical
engineer at AGCO Metalex, a large precious metals refinery in
Washington State. The son of a Ph.D. chemist, Boeing engineer and
mathematics major, he quickly went on to the Semiconductor
manufacturing industry for nearly a decade as a metallic silicon
coatings engineer, leaving to attend ASU West in Arizona. With an
engineering and metallurgical chemistry background, David switched
gears to Organic agricultural production for an additional eight
years. David was farm director and chief environmental scientist
for what was once the oldest Organic farm in the state of Colorado
before moving into the more advanced world of CBD, hemp production
and custom product development. David has spent years earning the
respect of CBD market leaders and forming solid business
relationships both in the US and abroad. His career began by making
the first CBD infused consumer product offered in the US with 99%
isolate, ‘CrystalPure CBD’ which is now sold under the Canbiola
brand.
Canbiola will be attending the Integrative Healthcare
Symposium Annual Conference on February 22-24, 2018 in New York
City. Come join us and learn about the benefits of our products.
(Booth # 638)
About Canbiola, Inc.
Canbiola, Inc. is a public company trading under symbol CANB.
Canbiola, Inc. is a US Company embarking in the sale of a
variety of Cannabidiol (CBD) based products. Canbiola is in the
process of developing its own line of proprietary products as well
as seeking synergistic value through acquisitions in the CBD and
the medical cannabis industry. Cannabis is currently federally
illegal and has legalized for medical purposes in some form in a
limited number of states. The company has already launched several
products found at www.canbiola.com.
The company also owns two technological solutions, WRAPmail (US
Patent 8,572,275), which turns traditional email into a powerful
marketing and branding tool, as well Prosperity Systems and the
Bullseye platform of document management and compliance targeted at
broker-dealers, public companies, and governmental agencies
providing a flawless all-in-one solution for document management,
retention and compliance.
Forward-looking statements and risks and uncertainties Matters
discussed in this press release contain forward-looking statements.
The words "anticipate," "believe," "estimate," "may," "intend,"
"expect," and similar expressions identify such forward-looking
statements. Expected, actual results, performance, or achievements
could differ materially from those contemplated, expressed, or
implied by the forward-looking statements contained herein.
Forward-looking statements are subject to a number of risks and
uncertainties, including but not limited to, risks and
uncertainties associated with, among other things, the impact of
economic, competitive, and other factors affecting our operations,
markets, products, and performance. The matters discussed herein
should not be construed in any way, shape or manner of our future
financial condition or stock price.
Canbiola Investor Relations Email: IR@canbiola.com Phone: (516) 595-9544 website: http://www.canbiola.com Follow us on Twitter and Facebook